Method of treating cancer with a two-component anti-cancer composition

US10494392B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10494392-B2
Application numberUS-201916404355-A
CountryUS
Kind codeB2
Filing dateMay 6, 2019
Priority dateApr 17, 2017
Publication dateDec 3, 2019
Grant dateDec 3, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Gold(I) complexes and gold(I) dithiocarbamate polymers as anticancer therapeutics. The Au(I) ion within the gold(I) complexes is coordinated to two phosphine ligands. The repeating unit formed by Au(I) ion coordinating to dithiocarbamate ligands are connected by Au(I)—Au(I) interactions within the gold(I) dithiocarbamate polymers. Also disclosed are methods of synthesis, pharmaceutical compositions incorporating the gold(I) complexes, pharmaceutical compositions incorporating the gold(I) dithiocarbamate polymers, and methods of treating cancer.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of treating cancer, comprising: administering a gold/cis-platin composition to a subject in need of therapy of at least one of lung cancer, colon cancer, and breast cancer, wherein the gold/cis-platin composition comprises cis-platin and a gold(I) complex of formula (I): or a salt thereof, a tautomer thereof, a stereoisomer thereof, or a mixture thereof, wherein R 1 , R 2 , R 3 , and R 4 are independently selected from the group consisting, of a hydrogen, an optionally substituted alkyl, an optionally substituted alkoxy, and a nitro; R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12 are independently selected from the group consisting of a hydrogen, an optionally substituted alkyl; and X is an anion. 2. The method of claim 1 , wherein the cancer is resistant to cisplatin. 3. The method of claim 1 , wherein 1-300 mg/kg of gold(I) complex of formula (I) is administered per body weight of the subject.

Assignees

Inventors

Classifications

  • Gold compounds · CPC title

  • C07F9/5045Primary

    Complexes or chelates of phosphines with metallic compounds or metals · CPC title

  • Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795 · CPC title

  • Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon {with or without the latter elements in the main chain of the macromolecule} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10494392B2 cover?
Gold(I) complexes and gold(I) dithiocarbamate polymers as anticancer therapeutics. The Au(I) ion within the gold(I) complexes is coordinated to two phosphine ligands. The repeating unit formed by Au(I) ion coordinating to dithiocarbamate ligands are connected by Au(I)—Au(I) interactions within the gold(I) dithiocarbamate polymers. Also disclosed are methods of synthesis, pharmaceutical composit…
Who is the assignee on this patent?
Univ King Fahd Pet & Minerals
What technology area does this patent fall under?
Primary CPC classification C07F9/5045. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).